Delcath Systems
DCTH
18.79
-0.45
-2.34%
Delcath Systems
US · DCTH
#3706 by market cap
18.79
-0.45
-2.34%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Delcath Systems
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
- Founded
- 1988
- CEO
- Mr. Gerard J. Michel
- Employees
- 156
- Headquarters
- Queensbury, New York, United States of America
- Fiscal year end
- 12-31
- Website
- delcath.com
Company profile
- Exchange
- US
- Symbol
- DCTH
- Market-cap rank
- #3706
- Market cap
- 653.67M
- Float cap
- 495.35M
- Shares out
- 34.79M
- Float shares
- 26.36M
Sectors & themes
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Delcath Systems discussion 0 comments